RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Robert Holt to Colorectal Neoplasms

Back to Details
This is a "connection" page, showing publications Robert Holt has written about Colorectal Neoplasms.
Robert Holt
Connection Strength
1.001
Colorectal Neoplasms
  1. Holt RA. Oncomicrobial vaccines: The potential for a Fusobacterium nucleatum vaccine to improve colorectal cancer outcomes. Cell Host Microbe. 2023 01 11; 31(1):141-145.
    View in: PubMed
    Score: 0.592
  2. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, Holt RA. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012 Feb; 22(2):299-306.
    View in: PubMed
    Score: 0.272
  3. Rye MS, Garrett KL, Holt RA, Platell CF, McCoy MJ. Fusobacterium nucleatum and Bacteroides fragilis detection in colorectal tumours: Optimal target site and correlation with total bacterial load. PLoS One. 2022; 17(1):e0262416.
    View in: PubMed
    Score: 0.138
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support